Patent · US Active

Method of targeting gene delivery using viral vectors

US9994867B2 · kind B2 · utility

6Cited by
28References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 23, 2014
Grant dateJun 12, 2018
Priority date
Expiry dateNov 28, 2034

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compositions are provided for delivering a polynucleotide encoding a gene of interest to a target cell using a virus. The virus envelope comprises a cell-specific binding determinant that recognizes and binds to a component on the target cell surface, leading to endocytosis of the virus. A separate fusogenic molecule is also present on the envelope and facilitates delivery of the polynucleotide across the membrane and into the cytosol of the target cell. The methods and related compositions can be used for treating patients having suffering from a wide range of conditions, including infection, such as HIV; cancers, such as non-Hodgkin's lymphoma and breast cancer; and hematological disorders, such as severe combined immunodeficiency.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.